Zydus Lifesciences Buyback 2024

Zydus Lifesciences Limited Buyback

Zydus Lifesciences Buyback 2024
Tender Offer

₹1,005.00

Buyback price per share

About Zydus Lifesciences Limited Buyback

Zydus Lifesciences Limited is a leading Indian Pharmaceutical company that offers healthcare services globally.

The company manufactures formulations, APIs, vaccines, biosimilars, complex products (transdermals, topical etc.), animal health products as well as wellness products.

Zydus Lifesciences Limited has more than 30 manufacturing plants worldwide including India, Germany, Brazil & USA. Zydus Lifesciences Limited is the fourth largest pharmaceutical company in India. Zydus Lifesciences was formerly known as Cadila Healthcare Limited.

Read More

Zydus Lifesciences Limited Buyback Details

Security Name

Zydus Lifesciences Limited

Buyback Price

₹1,005.00

Face Value

₹1.00

Listing at Group

BSE, NSE

Lead Manager

ICICI Securities Limited

Buyback Docs

Letter Of Offer

Issue Size

5,970,149 (0.59 % of Total number of equity Shares)

Zydus Lifesciences Buyback 2024 Issue Timetable

Last Date to buy sharesRecord DateOffer Opens OnOffer Closes On *
Feb 22, 2024Feb 23, 2024Feb 29, 2024Mar 6, 2024
Last Date for receipt of Tender FormsFinalisation of Buyback AcceptanceLast Date for settlement of bidsLast Date for Extinguishment of Shares
Mar 6, 2024Mar 13, 2024Mar 14, 2024Mar 26, 2024

Zydus Lifesciences Limited Buyback Ratio

CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders6/67895523
General Category for all other Eligible Shareholders2/3955074626

Company Financials All values are in ₹ Cr.

Period Ended31-Mar-2331-Mar-2231-Mar-21
Total Assets------
Net Worth17,515.8016,999.6012,992.30
Profit After Tax1,529.20857.901,476.20
Total Revenue9,553.508,160.607,869.30
Reserves And Surplus1,801.75----
Total Borrowing1,163.204,196.004,583.50

How to Participate in Zydus Lifesciences Limited Buyback?

1. Firstly, to be eligible for the buyback the investor should have shares of Zydus Lifesciences Limited Buyback in Demat or physical form as on the record date Feb 23, 2024.

2. Once you have shares in Demat, you can participate in the buyback process which is opening from Feb 29, 2024 by selling your shares through your broker on BSE, NSE.

3. Then on Mar 26, 2024, the payment will be given to you for accepted shares and unaccepted shares will be returned to your Demat account.

Calculation of Investment in Zydus Lifesciences Limited Buyback

Maximum market value of a share holder as on record date

₹200,000.00

Buyback price per share

₹1,005.00

Maximum share for small shareholders (200000/ 1005)

199.00 share

Closing price of stock as of 2024-02-09

₹801.85

Maximum amount insted in buyback (₹801.85 x 199.00497512437812 shares)

₹159,572.14

* No. of shares stands to change according to the closing price on the record date

* For simplicity, we have considered the price on date Feb 9, 2024


Expected Profit from the Zydus Lifesciences Limited Buyback on the bases of acceptance Ratio:

Acceptance Ratio

33%

50%

75%

100%

Amount Invested in Buyback

₹159,572.14

₹159,572.14

₹159,572.14

₹159,572.14

No. of Shares Buyback

65

99

149

199

Buyback Profit

13204

20111

30269

40426

Profit%

8.27%

12.60%

18.97%

25.33%

Zydus Lifesciences Limited Buyback - Necessity of the Objective

The Buyback will help the company to distribute a part of the surplus cash to its shareholders holding equity shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in the longer term, and improving the return on equity.

Company Contact Information

Zydus Lifesciences Limited Buyback

Zydus Corporate Park, Scheme No. 63, Khoraj (Gandhinagar), 536, Sarkhej-Gandhinagar Hwy, Near Vaishnodevi Circle, Ahmedabad 382481

Email: dhavalsoni@zyduslife.com

Phone: +91-79-71800000

Website: https://zyduslife.com/index

Zydus Lifesciences Buyback 2024 Registrar

Link Intime India Private Ltd

Email: zyduslife.buyback2024@linkintime.co.in

Phone: +91-22-4918 6270

Website: https://linkintime.co.in/initial_offer/public-issues.html